Virtus ETF Advisers’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,684
Closed -$117K 469
2023
Q3
$117K Sell
2,684
-268
-9% -$11.7K 0.07% 322
2023
Q2
$107K Buy
2,952
+634
+27% +$22.9K 0.06% 352
2023
Q1
$86.2K Sell
2,318
-885
-28% -$32.9K 0.05% 372
2022
Q4
$145K Buy
3,203
+1,214
+61% +$55K 0.08% 354
2022
Q3
$139K Buy
1,989
+14
+0.7% +$978 0.06% 365
2022
Q2
$133K Buy
1,975
+861
+77% +$58K 0.05% 344
2022
Q1
$92K Sell
1,114
-69
-6% -$5.7K 0.04% 317
2021
Q4
$174K Sell
1,183
-66
-5% -$9.71K 0.07% 267
2021
Q3
$221K Sell
1,249
-69
-5% -$12.2K 0.1% 242
2021
Q2
$213K Buy
1,318
+40
+3% +$6.46K 0.09% 302
2021
Q1
$219K Buy
1,278
+22
+2% +$3.77K 0.09% 313
2020
Q4
$276K Sell
1,256
-1,764
-58% -$388K 0.11% 262
2020
Q3
$501K Sell
3,020
-404
-12% -$67K 0.26% 138
2020
Q2
$391K Buy
3,424
+213
+7% +$24.3K 0.19% 206
2020
Q1
$247K Sell
3,211
-467
-13% -$35.9K 0.1% 253
2019
Q4
$474K Buy
3,678
+988
+37% +$127K 0.08% 210
2019
Q3
$210K Sell
2,690
-149
-5% -$11.6K 0.04% 238
2019
Q2
$292K Sell
2,839
-3,667
-56% -$377K 0.06% 228
2019
Q1
$477K Sell
6,506
-778
-11% -$57K 1.01% 31
2018
Q4
$309K Sell
7,284
-2,291
-24% -$97.2K 0.05% 102
2018
Q3
$451K Sell
9,575
-6,854
-42% -$323K 0.05% 137
2018
Q2
$810K Sell
16,429
-26,707
-62% -$1.32M 0.72% 24
2018
Q1
$1.32M Buy
43,136
+23,350
+118% +$717K 1.15% 11
2017
Q4
$361K Buy
+19,786
New +$361K 0.45% 75
2016
Q2
Sell
-7,828
Closed -$168K 152
2016
Q1
$168K Buy
+7,828
New +$168K 0.23% 109